Search Results - "Yeramian, A."

Refine Results
  1. 1

    Endometrial carcinoma: molecular alterations involved in tumor development and progression by Yeramian, A, Moreno-Bueno, G, Dolcet, X, Catasus, L, Abal, M, Colas, E, Reventos, J, Palacios, J, Prat, J, Matias-Guiu, X

    Published in Oncogene (24-01-2013)
    “…In the western world, endometrial carcinoma (EC) is the most common cancer of the female genital tract. The annual incidence has been estimated at 10–20 per…”
    Get full text
    Journal Article
  2. 2

    Molecular pathology of endometrial carcinoma: practical aspects from the diagnostic and therapeutic viewpoints by Llobet, D, Pallares, J, Yeramian, A, Santacana, M, Eritja, N, Velasco, A, Dolcet, X, Matias-Guiu, X

    Published in Journal of clinical pathology (01-09-2009)
    “…This article reviews the main molecular alterations involved in endometrial carcinoma. Five molecular features (microsatellite instability, and mutations in…”
    Get more information
    Journal Article
  3. 3
  4. 4

    CK2 controls TRAIL and Fas sensitivity by regulating FLIP levels in endometrial carcinoma cells by Llobet, D, Eritja, N, Encinas, M, Llecha, N, Yeramian, A, Pallares, J, Sorolla, A, Gonzalez-Tallada, F J, Matias-Guiu, X, Dolcet, X

    Published in Oncogene (17-04-2008)
    “…Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) has emerged as a promising antineoplastic agent because of its ability to selectively kill…”
    Get full text
    Journal Article
  5. 5

    The multikinase inhibitor Sorafenib induces apoptosis and sensitises endometrial cancer cells to TRAIL by different mechanisms by Llobet, D, Eritja, N, Yeramian, A, Pallares, J, Sorolla, A, Domingo, M, Santacana, M, Gonzalez-Tallada, F.J, Matias-Guiu, X, Dolcet, X

    Published in European journal of cancer (1990) (01-03-2010)
    “…Abstract Sorafenib induces apoptosis and enhances Tumour Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)-induced cell killing of tumoural cells. We…”
    Get full text
    Journal Article
  6. 6

    Effect of proteasome inhibitors on proliferation and apoptosis of human cutaneous melanoma-derived cell lines by Sorolla, A., Yeramian, A., Dolcet, X., Pérez de Santos, A.M., Llobet, D., Schoenenberger, J.A., Casanova, J.M., Soria, X., Egido, R., Llombart, A., Vilella, R., Matias-Guiu, X., Marti, R.M.

    Published in British journal of dermatology (1951) (01-03-2008)
    “…Summary Background  Cutaneous malignant melanoma is an aggressive type of skin cancer which causes disproportionate mortality in young and middle‐aged adults…”
    Get full text
    Journal Article
  7. 7

    New Therapeutic Targets in Melanoma by Martí, R.M, Sorolla, A, Yeramian, A

    Published in Actas dermo-sifiliográficas (English ed.) (01-09-2012)
    “…Abstract Research into molecular targets for drug development in melanoma is starting to bear fruit. Of the drugs tested to date in patients with metastatic…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Fischer–Tropsch reaction on Fe/Zeolite-L system. Structure and catalytic behavior by Bengoa, J.F, Alvarez, A.M, Cagnoli, M.V, Gallegos, N.G, Yeramián, A.A, Marchetti, S.G

    Published in Materials letters (01-03-2002)
    “…Iron supported on potassic and acidic forms of commercial zeolite-L were used to determine the role played by the small metallic crystallites inside the…”
    Get full text
    Journal Article
  11. 11

    Study of the Fe/zeolite-L system: Part I: Characterization of iron species and their structural properties by Marchetti, S.G, Cagnoli, M.V, Alvarez, A.M, Bengoa, J.F, Mercader, R.C, Yeramián, A.A

    Published in Applied surface science (22-09-2000)
    “…Zeolite-L in potassic (ZLK) and acidic (ZLH) forms were used as a support for iron species to obtain two solids, called Fe/ZLK and Fe/ZLH, respectively. “In…”
    Get full text
    Journal Article
  12. 12

    Selectivity to Olefins of Fe/SiO2–MgO Catalysts in the Fischer–Tropsch Reaction by Gallegos, N.G., Alvarez, A.M., Cagnoli, M.V., Bengoa, J.F., Marchetti, S.G., Mercader, R.C., Yeramian, A.A.

    Published in Journal of catalysis (01-06-1996)
    “…SiO2covered with MgO has been used as support of iron catalysts in the Fischer–Tropsch reaction. Catalysts of 5% (w/w) iron concentration and 2, 4, and 8%…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Phytochemical and biological investigations of Atriplex semibacata R .BR. growing in Egypt by Tawfik, Wafaa A, Abdel-Mohsen, Mona M, Radwan, Hany M, Habib, Amira A, Yeramian, M A

    “…The lipid content of Atriplex semibacata growing in Egypt was studied. The unsaponifiable fraction was identified by GLC. A series of hydrocarbons ranging from…”
    Get full text
    Journal Article
  15. 15

    Stacking Faults Effects on Shape Selectivity of Offretite by Bengoa, J. F, Marchetti, S. G, Gallegos, N. G, Alvarez, A. M, Cagnoli, M. V, Yeramian, A. A

    “…The cocrystallization of erionite during the synthesis of tetramethylammonium−offretite produces faults in the crystalline structure known as stacking faults…”
    Get full text
    Journal Article
  16. 16

    Long-Term Estradiol Exposure Is a Direct Mitogen for Insulin/EGF-Primed Endometrial Cells and Drives PTEN Loss-Induced Hyperplasic Growth by Eritja, Nuria, Mirantes, Cristina, Llobet, David, Yeramian, Andree, Bergadà, Laura, Dosil, Mari A, Domingo, Mónica, Matias-Guiu, Xavier, Dolcet, Xavier

    Published in The American journal of pathology (01-07-2013)
    “…Loss of tumor-suppressor PTEN is the most common alteration in endometrial carcinoma. However, the relationship between loss of PTEN , growth factors [eg,…”
    Get full text
    Journal Article
  17. 17

    Catalytic CO hydrogenation on potassic Fe/zeolite LTL by Cagnoli, M.V., Gallegos, N.G., Alvarez, A.M., Bengoa, J.F., Yeramián, A.A., Schmal, M., Marchetti, S.G.

    Published in Applied catalysis. A, General (30-04-2002)
    “…Zeolite LTL in the potassic form ( K-LTL) was used as support of iron. The precursor was characterized by temperature programmed reduction (TPR) and Mössbauer…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Targeting the extrinsic apoptotic pathway in endometrial carcinoma cell lines and tumor cell explants by Matias-guiu, X., Dolcet, X., Llobet, D., Poveda, A., Pallares, J., Eritia, N., Yeramian, A., Sorolla, A., Ortega, E., Llombart-Cussac, A.

    Published in Journal of clinical oncology (20-05-2009)
    “…Abstract only e16555 Background: Endometrial carcinoma (EC) frequently shows deregulation of the extrinsic apoptotic pathway. One of the critical regulators of…”
    Get full text
    Journal Article